InvestorsHub Logo
Followers 61
Posts 595
Boards Moderated 0
Alias Born 08/10/2014

Re: None

Monday, 04/12/2021 10:07:16 PM

Monday, April 12, 2021 10:07:16 PM

Post# of 403243
Interim analysis:
From the trial protocol:

The study will start with 3 days of study drug administration. After an interim analysis safety review, by an independent Data Monitoring Committee (DMC), dosing may be extended to 5 days.



That's pretty clear.

https://clinicaltrials.gov/ct2/show/NCT04784897?term=brilacidin&draw=2&rank=2

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News